# Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)

> **NCT04053790** · PHASE4 · COMPLETED · sponsor: **Hospital General de Mexico** · enrollment: 177 (actual)

## Conditions studied

- Irritable Bowel Syndrome With Diarrhea

## Interventions

- **DRUG:** lactobacillus LB
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT04053790
- **Lead sponsor:** Hospital General de Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2023-01-29
- **Final completion:** 2023-01-29
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053790, "Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04053790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*